{"status":"ok","data":[{"num":"1","id":48,"title":"Lehigh Valley Suite Spot: Q&A With OraSure Technologies CEO Carrie Eglinton Manner","date":{"date":"2023-06-14 09:22:31.867000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"As an engineer, OraSure Technologies<\/strong><\/a> CEO Carrie Eglinton Manner understands the mathematical relationships that underpin the technology essential to our lives.<\/span>As a veteran health care executive, Eglinton Manner knows that strong, working relationships drive those scientific breakthroughs.<\/span>From unlocking genetic drivers of disease to advocating for breastfeeding resources at the office, Eglinton Manner has built her career on forging common ground with colleagues of diverse backgrounds and expertise to find solutions that impact lives in a meaningful way.<\/span>\u201cI am always looking for the common thread, the shared experiences. That's the theme throughout my career,\u201d Eglinton Manner said. \u201cWhile, in some ways it could feel like we were blazing trails, what I was always looking for was the commonalities: shared experiences, common challenges.\u201d<\/span>","link":"https:\/\/www.lehighvalley.org\/lehigh-valley-suite-spot-q-a-with-orasure-technologies-ceo-carrie-eglinton-manner\/"},{"num":"2","id":47,"title":"These Are the Best At-Home Covid Tests You Can Buy Online","date":{"date":"2022-06-27 13:23:53.890000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Covid-19 is everywhere, and public health experts have made it clear this virus isn\u2019t going away anytime soon. Because of this, it\u2019s important to keep home Covid tests handy in case you or someone in your household develops symptoms.<\/span>While there used to only be a few options for home tests, you now can choose from a slew of different products. Sure, more options are better, but that also makes it difficult to know which is best. Just know this: The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) to several tests<\/a> and, at baseline, the test you choose should meet this criteria. (An EUA, in case you\u2019re not familiar with it, essentially says that the known benefits of using the product outweigh any potential cons. However, it\u2019s not a full authorization\u2014that process typically takes years.)<\/span>","link":"https:\/\/www.oprahdaily.com\/life\/health\/g40300691\/best-covid-home-tests\/"},{"num":"3","id":46,"title":"Mack Trucks wasn\u2019t the only Lehigh Valley company that Joe Biden praised in speech","date":{"date":"2021-07-29 11:57:10.250000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"It wasn\u2019t just Mack Trucks<\/a> that got a shoutout when President Joe Biden<\/a> gave a speech from the Lehigh Valley factory floor<\/a> on Wednesday, his first time in the area as president.<\/span>The Scranton native also lauded another nearby company \u2014 OraSure<\/a>, maker of an at-home COVID-19 test<\/a>.<\/span>\u201cJust down the road in Bethlehem \u2014 er, up the road in Bethlehem. I think about it coming from Scranton,\u201d Biden said, waving his finger in two different directions.<\/span>The audience was small \u2014 about 100 people or so \u2014 and rapt by Biden\u2019s speech on plans to enhance American business by <\/span>boosting federal purchases of domestic products<\/a> and encouraging citizens to do the same.<\/span><\/span>","link":"https:\/\/www.lehighvalleylive.com\/lehigh-county\/2021\/07\/mack-trucks-wasnt-the-only-lehigh-valley-company-that-joe-biden-praised-in-speech.html?fbclid=IwAR1t1Cl4gmM1SW82P2W0X8Zc0kBiux4oULqwpIE62OWgQlSJGMFqHYLIasU"},{"num":"4","id":44,"title":"\u2018Testing will continue to play a crucial role,\u2019 OraSure CEO says as firm seeks FDA authorization for COVID-19 rapid test","date":{"date":"2021-03-31 15:46:14.780000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure Technologies Inc. has developed a COVID-19 rapid self-test in which a person swabs their lower nostrils, swirls the test stick in a pre-measured solution and then gets the result a short time later.<\/span>Before the test can get to market, the Bethlehem company needs the OK from the U.S. Food and Drug Administration.<\/span>OraSure on Tuesday announced it has submitted an application to the FDA for emergency use authorization of its rapid antigen test for prescription home use and professional use. The professional test would be used at drive-thru sites, doctors\u2019 offices and public health sites, while the prescription test is for at-home use by consumers with a prescription.<\/span>","link":"https:\/\/www.mcall.com\/business\/mc-biz-orasure-technologies-seeks-fda-eua-for-covid-home-test-20210330-nlfsbdoc4zaehczn2jxhv2ymnm-story.html"},{"num":"5","id":43,"title":"What\u2019s up with OraSure\u2019s COVID-19 self-test? Bethlehem company expanding as it seeks FDA authorization","date":{"date":"2021-03-09 08:51:28.070000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"When reflecting on his company\u2019s efforts over the past year to develop a COVID-19 rapid self-test and the road ahead, Stephen Tang thinks about it like a relay race.<\/span>\u201cYou move from R&D to manufacturing to sales and marketing, and everybody has their role in the race,\u201d said Tang, president and CEO of OraSure Technologies Inc. \u201cThose that aren\u2019t running right now are getting ready to run \u2014 and run quickly.\u201d<\/span>","link":"https:\/\/www.mcall.com\/business\/mc-biz-orasure-provides-update-on-covid-rapid-self-test-20210302-ggsb5bksevfwbpjtn6s7kcuc2e-story.html"},{"num":"6","id":42,"title":"Your View by Bethlehem executives: Ways to reduce HIV disparities in Black communities","date":{"date":"2021-02-08 08:38:40.133000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Feb. 7, National Black HIV\/AIDS Awareness Day, is a day to highlight the disproportionate impact of HIV on Black communities, to celebrate the work of Black HIV advocates, and to support Black people living with HIV in America.<\/span>We also celebrate the efforts of our local and federal partners, the HIV workforce and community advocates who have made monumental strides in reducing new HIV infections and continue to champion the Ending the HIV Epidemic Initiative. That effort aims to reduce new HIV infections nationally by 75% in the next five years<\/strong><\/a>, then by at least 90% within 10 years.<\/span>Today is an exciting time. Therapeutics exist that can both prevent and treat HIV, making eradication of this disease achievable.<\/span>","link":"https:\/\/www.mcall.com\/opinion\/mc-opi-hiv-health-disparities-black-americans-daughtridge-20210206-6bwndwi3vrgbzchqb3ppidogky-story.html"},{"num":"7","id":40,"title":"At-home COVID tests: Advancing do-it-yourself diagnostics","date":{"date":"2020-12-06 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"The town of Bethlehem, Pennsylvania was famous for producing steel. But the smokestacks are relics. Now, a very different kind of industry is thriving in the Lehigh Valley.<\/span><\/span>\"This company was actually founded in the shadows of the old Bethlehem Steel,\" said Stephen Tang, the CEO of OraSure Technologies, a biotech company that produces diagnostic tests you can do at home. As millions of Americans lost their jobs last spring, OraSure started hiring.<\/span><\/span>","link":"https:\/\/www.cbsnews.com\/news\/at-home-covid-tests-advancing-do-it-yourself-diagnostics\/"},{"num":"8","id":36,"title":"OraSure\u2019s OMNIgene\u00ae\u00b7ORAL Sample Collection Kit Named to TIME\u2019s Best Inventions of 2020 List","date":{"date":"2020-11-20 09:04:27.937000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure is helping make COVID-19 testing\u2014and quick results\u2014more accessible. The company received among the first emergency-use authorizations from the FDA for an at-home COVID-19 sample-\u00adcollection kit. Instead of going to a health professional and having a swab thrust up their noses, users spit into the OMNIgene Oral collection tube and send it to a lab, which then turns around the results in a day or two. Such collection kits, which anyone can order online, could vastly expand the reach of COVID-19 testing.<\/span><\/span>","link":"https:\/\/time.com\/collection\/best-inventions-2020\/5911390\/orasure-omnigene-oral\/"},{"num":"9","id":34,"title":"Better, Faster Testing Is the Path to an American Comeback","date":{"date":"2020-10-08 10:11:02.657000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"As undergraduates returned to the University of Arizona<\/a> for the fall semester, many of the new precautions were hard to miss. Plexiglass dividers were affixed in front of lecterns and between lab benches. Giant tents were set up so students arriving early for a class could wait outdoors, sheltered from the punishing sun. Roving teams of student \u201chealth ambassadors\u201d tooled around in golf carts, handing out masks and politely chiding their peers for standing less than 6 feet apart.<\/span>But the first thing students had to do was visit one of the university gyms for a rapid SARS-CoV-2 test. The results took an hour. Negative, and you could move into your residence hall right away. Positive, and you were sent to a special isolation dorm, where you spent the next 10 days taking classes online.<\/span>","link":"https:\/\/www.bloomberg.com\/news\/features\/2020-10-01\/coronavirus-pandemic-how-the-u-s-can-implement-rapid-covid-testing"},{"num":"10","id":32,"title":"MAC Cosmetics Former Chief Chemist Launches Pure Culture Beauty, A 23andMe-Inspired Skincare Line","date":{"date":"2020-09-16 07:07:07.863000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"The skincare market is already clogged to the pores with prestige labels and indie brands alike. And as clear-complexioned celebrities ranging from Jennifer Lopez to Rihanna, Kylie Jenner, Selena Gomez, Drew Barrymore, Millie Bobby Brown and more bottle up their own lines of creams, serums and toners, the industry is bound to get only more competitive through 2020. According to the <\/span>NPD Group<\/a>, in 2019, skincare was the second fastest growing segment under the $140 billion U.S. beauty industry.<\/span><\/span>But this isn\u2019t deterring Victor Casale from starting his own venture. The former chief chemist of <\/span>MAC Cosmetics<\/a> is launching Pure Culture Beauty today. The scientist and serial entrepreneur hopes his skincare credentials as well as the increasingly discerning consumer focuses less on the star-power and more on the innovation behind a brand.<\/span><\/span>","link":"https:\/\/www.forbes.com\/sites\/tanyaklich\/2020\/09\/15\/23andme-inspires-mac-cofounder-to-launch-pure-culture-beauty\/#74dda47e7f9c"},{"num":"11","id":31,"title":"Five things to know about frequent mass testing for COVID-19","date":{"date":"2020-09-11 12:29:10.920000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"University of Illinois chemistry professor Marty Burke, along with his research team, designed an aggressive testing program to allow the university to reopen this fall. Some experts say it should be a model for the rest of the country.<\/span>Meanwhile, researchers at more than two dozen companies are working on at-home coronavirus tests that could allow that kind of frequent mass testing to happen on a national scale. <\/span>","link":"https:\/\/www.cbsnews.com\/news\/five-things-to-know-frequent-mass-testing-for-covid-19\/"},{"num":"12","id":30,"title":"Public Health Officials Pursue Covid-19 Tests That Trade Precision for Speed","date":{"date":"2020-09-11 12:28:41.747000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Public health experts are increasingly calling for a shift in thinking about Covid-19 testing: It is better to get fast, frequent results that are reasonably accurate than more precise results after dayslong delays.<\/span>Diagnostic companies are racing to develop quicker, cheaper Covid-19 diagnostic tests<\/a>, and tests that can be done at doctors\u2019 offices, nursing homes and other places with the assistance of a medical provider are gradually becoming more widespread.<\/span>The U.S. Food and Drug Administration has authorized four such tests that are antigen-based, meaning they search for viral proteins. Test makers have vowed to produce tens of millions of these quick-turnaround tests in coming months, including Abbott Laboratories which recently unveiled a test that costs $5<\/a> and is the size of a credit card.<\/span>","link":"https:\/\/www.wsj.com\/articles\/public-health-officials-pursue-covid-19-tests-that-trade-precision-for-speed-11599562800?mod=searchresults&page=1&pos=1"},{"num":"13","id":29,"title":"Saliva test could fill COVID-19 assessment gaps: Ottawa study","date":{"date":"2020-09-09 14:34:06.660000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"At the beginning of the pandemic, Ottawa surgeon Dr. Stephanie Johnson-Obaseki had a brainwave resulting in research that could lead to saliva testing becoming another tool in the toolbox of COVID-19 assessment.<\/span>Johnson-Obaseki, who is a head and neck cancer surgeon at The Ottawa Hospital and normally researches human papillomavirus in head and neck tumours, had previously worked on HPV testing using kits designed by Ottawa company DNA Genotek. When the pandemic hit and other research slowed down, she began thinking of those kits.<\/span>","link":"https:\/\/ottawacitizen.com\/news\/local-news\/saliva-test-could-fill-covid-19-assessment-gaps-ottawa-study"},{"num":"14","id":28,"title":"The U.S. needs to democratize COVID testing","date":{"date":"2020-08-25 09:36:14.953000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Right now, we stand on a precipice. Global disruption like the world is currently experiencing presents an opportunity for each one of us to stand up and be on the right side of history. We are grappling with the COVID-19 pandemic and its implications for public health. At the same time, protesters have taken to the streets to speak out against decades of systemic, pervasive racism.<\/span>These two issues are deeply connected. It has been well understood that advanced age and preexisting conditions increase the chance of becoming very sick with COVID-19. Initiatives such as the COVID Racial Data Tracker opened a window into the effect of COVID on communities of color. However, it wasn\u2019t until the CDC\u2019s more comprehensive morbidity and mortality data were made public (after a lawsuit) that it became frighteningly clear that vulnerable communities were bearing an undue burden.<\/span>","link":"https:\/\/www.inquirer.com\/opinion\/commentary\/coronavirus-testing-at-home-self-administered-philadelphia-pennsylvania-20200820.html"},{"num":"15","id":27,"title":"The Push to Deploy At-Home Antigen Tests for COVID-19","date":{"date":"2020-08-25 09:35:55.587000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Testing backlogs, reagent shortages, and limited access have contributed to inadequate testing for COVID-19 in the US and elsewhere. But in recent months, new types of assay that promise to offer quicker, cheaper, and more user-friendly features have begun to roll out. Saliva tests, for one, are gaining traction as screening tools for universities and professional basketball teams. Antigen testing is another approach that, if given regulators' blessings, might give consumers the ability to take their own tests at home and get results on the spot.<\/span>Several diagnostics firms are currently working to gain regulatory approval and bring products like this to market in huge numbers.<\/span>","link":"https:\/\/www.the-scientist.com\/news-opinion\/the-push-to-deploy-at-home-antigen-tests-for-covid-19-67831"},{"num":"16","id":26,"title":"In race for coronavirus test, OraSure to expand, create 177 jobs in Bethlehem as it works to bring 'lab on a swab' to market","date":{"date":"2020-08-25 09:35:36.790000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure Technologies Inc. believes it is nearing the finish line in the race to bring a rapid at-home coronavirus test into the market by the end of 2020.<\/span>To prepare, the Bethlehem diagnostic testing company joined state officials in Harrisburg on Tuesday to announce an expansion in the Lehigh Valley that will help the firm keep pace with anticipated manufacturing demand. The expansion will create 177 full-time jobs and retain 233 positions across three OraSure locations in Bethlehem and one in Bethlehem Township.<\/span>","link":"https:\/\/www.mcall.com\/business\/mc-biz-orasure-covid-expansion-tom-wolf-announcement-20200811-vrlm3yvkzngargijdvomorc34y-story.html"},{"num":"17","id":24,"title":"Bethlehem's OraSure to expand amid development of at-home virus test","date":{"date":"2020-08-25 09:34:48.023000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure Technologies is expanding manufacturing operations as it works to develop both an at-home COVID-19 test and lab-based antibody test.<\/span>The Bethlehem-based company, which develops and makes diagnostic tests and medical devices, will create 177 new, full-time manufacturing jobs, and retain 233 jobs, announced Gov. Tom Wolf's administration on Tuesday.<\/span>","link":"https:\/\/www.wfmz.com\/business\/bethlehems-orasure-to-expand-amid-development-of-at-home-virus-test\/article_398b80e2-dbe2-11ea-9848-9f2e331acdbb.html"},{"num":"18","id":23,"title":"Bethlehem company expects at-home test to launch within months","date":{"date":"2020-08-25 09:34:27.727000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Bethlehem-based OraSure Technologies Inc. said Wednesday it anticipates a fourth-quarter 2020 launch of its in-home test kits for current and past infections of COVID-19.<\/span>OraSure says oral fluid collection devices from its DNA Genotek subsidiary are already in use for sample collection in the fight against the coronavirus illness, under U.S. Food and Drug Administration Emergency Use Authorizations. Its devices are helping in the push to return to work and to school across the country, according to a news release from the company Wednesday.<\/span>","link":"https:\/\/www.lehighvalleylive.com\/coronavirus\/2020\/08\/want-to-know-if-you-have-covid-19-bethlehem-company-expects-at-home-test-to-launch-within-months.html"},{"num":"19","id":22,"title":"Your View: Let\u2019s democratize COVID-19 testing","date":{"date":"2020-08-25 09:34:04.653000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Right now, at this very moment in time, we stand on a precipice. Global disruption like we are currently experiencing presents an opportunity for each and every one of us to stand up and be on the right side of history. The world is grappling with the COVID-19 pandemic and its implications for public health. At the same time, protesters have taken to the streets to speak out against decades of systemic, pervasive racism. On the surface, it would appear these two sets of circumstances have nothing in common, but when you dig deeper nothing could be further from the truth.<\/span>It has been well understood that advanced age and pre-existing conditions increased the chance of becoming very sick with COVID-19. Initiatives such as The COVID Racial Data Tracker opened a window onto the effect of COVID-19 on communities of color. However, it wasn\u2019t until the Centers for Disease Control and Prevention\u2019s more comprehensive morbidity and mortality data were made public (after a lawsuit), that it became frighteningly clear that vulnerable communities were bearing an undue burden.<\/span>","link":"https:\/\/www.mcall.com\/opinion\/mc-opi-democratize-covid-testing-tang-20200731-zbor5flmazckjfrpxttucywetm-story.html"},{"num":"20","id":21,"title":"A New Generation of Fast Coronavirus Tests Is Coming","date":{"date":"2020-08-25 09:33:41.333000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Researchers around the world are working on the next generation of coronavirus tests that give answers in less than an hour, without onerous equipment or highly trained personnel.<\/span>The latest so-called point-of-care tests, which could be done in a doctor\u2019s office or even at home, would be a welcome upgrade from today\u2019s status quo: uncomfortable swabs that snake up the nose and can take several days to produce results.<\/span>","link":"https:\/\/www.nytimes.com\/2020\/07\/06\/health\/fast-coronavirus-tests.html"},{"num":"21","id":20,"title":"Bethlehem firm\u2019s spit test for COVID-19 is coming closer","date":{"date":"2020-08-25 09:33:23.003000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"In the shadow of the hulking Bethlehem Steel foundry, whose long-idled smokestacks stand like tombstones for the defunct industrial giant, a Pennsylvania technology company is racing to \"democratize\" testing for COVID-19.<\/span>By September, Bethlehem's OraSure Technologies Inc. hopes to have a rapid, oral-fluid self-test on the market, one as quick and simple to use as those that can detect pregnancies. Available over the counter and able to produce results within 20 minutes, it likely would sell for less than $50, though recent federal law mandates that all public and private insurance plans must cover the cost of COVID-19 testing.<\/span>","link":"https:\/\/www.inquirer.com\/news\/spit-test-covid-coronavirus-orasure-fda-hiv--20200706.html"},{"num":"22","id":19,"title":"Secaucus genomics firm\u2019s at-home COVID-19 saliva test gets FDA approval","date":{"date":"2020-08-25 09:33:03.597000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"After a rigorous round of validation studies, Phosphorus, a genomics firm headquartered in New York City with a laboratory in Secaucus, said Monday that the U.S. Food and Drug Administration granted an Emergency Use Authorization request for its saliva test for COVID-19, which features at-home sample collection.<\/span>OraSure's Oragene\u00b7Dx (OGD-510) saliva collection device proved to be a reliable method for test performance comparable to gold standard methods. The tests were developed at Phosphorus\u2019 CLIA laboratory in Secaucus\u2014only the second at-home, unsupervised saliva test approved so far by the FDA.<\/span>","link":"https:\/\/njbiz.com\/secaucus-genomics-firms-home-covid-19-saliva-test-gets-fda-approval\/"},{"num":"23","id":18,"title":"Five COVID-19 Test Developers to Watch","date":{"date":"2020-08-25 09:32:44.727000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"A consensus of experts has agreed that the U.S. needs much more COVID-19. As of today, according to Worldometer, there have been more than 16.3 million COVID-19 tests completed in the U.S. However, far less agreement exists on how many more tests are needed daily, order for federal, state, and local governments to have the information needed to manage social distancing policies.<\/span>In a report published April 20, a group of 23 experts in economics, public health, technology, and ethics recommended that the nation ramp up to at least 5 million tests per day by early June to help ensure a safe social opening\u2014and to 20 million tests per day by mid-summer in order to fully re-mobilize the economy. Those findings appear in \u201cRoadmap to Pandemic Resilience: Massive Scale Testing, Tracing, and Supported Isolation (TTSI) as the Path to Pandemic Resilience for a Free Society,\u201d published by the Edmond J. Safra Center for Ethics at Harvard University, with support from The Rockefeller Foundation.<\/span>","link":"https:\/\/www.clinicalomics.com\/topics\/molecular-dx-topic\/molecular-diagnostics-in-vitro-diagnostics\/five-covid-19-test-developers-to-watch\/"},{"num":"24","id":17,"title":"Medication adherence startup UrSure acquired by Pennsylvania firm","date":{"date":"2020-08-25 09:32:10.697000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Boston-based startup and Harvard i-lab veteran UrSure, which makes urine tests to help doctors and patients improve medication adherence\u2014particularly to treat HIV infections\u2014is set to be acquired by Pennsylvania company OraSure Technologies for $3 million upfront, with an additional $28 million in payments contingent on specific milestones.<\/span>UrSure was founded by two physicians, Helen Koenig and Giffin Daughtridge, who noticed that patients at their HIV prevention clinic were still testing positive for HIV, even though they were routinely picking up their PrEP (short for Pre-Exposure Prophylaxis) medication, Truvada.<\/span>","link":"https:\/\/www.americaninno.com\/boston\/inno-news-boston\/medication-adherence-startup-ursure-acquired-by-pennsylvania-firm\/"},{"num":"25","id":16,"title":"Race Is On to Create Rapid Covid-19 Tests for the Fall","date":{"date":"2020-08-25 09:30:31.323000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Even as coronavirus testing ramps up around the country, businesses and public-health authorities seeking to safely reopen are hitting a speed-bump: Standard testing techniques still require sophisticated lab equipment and can take hours or even days for results.<\/span>To stretch beyond the lab, test developers are racing to produce next-stage technologies that could allow for rapid widespread testing as quickly as an at-home pregnancy test.<\/span>","link":"https:\/\/www.wsj.com\/articles\/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400"},{"num":"26","id":14,"title":"DNA Genotek's ORAcollect®•RNA kit included in EUA granted to Biocerna SARS-CoV-2 test","date":{"date":"2020-05-04 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OTTAWA, May 04, 2020 (GLOBE NEWSWIRE) -- DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its ORAcollect®•RNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples under a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) granted to Biocerna LLC for its PCR-based SARS-CoV-2 assay.

The Biocerna assay, combined with the ORAcollect®•RNA collection kit, is designed to allow for self-collection of nasal samples for the purpose of detecting the SARS-CoV-2 genome using the ThermoFisher Scientific TaqPath COVID-19 Combo Kit under the supervision of a healthcare provider. ORAcollect®•RNA is an all-in-one system for the collection, stabilization and transportation of human, microbial and viral RNA.","link":"http:\/\/www.globenewswire.com\/news-release\/2020\/05\/04\/2026578\/0\/en\/DNA-Genotek-s-ORAcollect-RNA-kit-included-in-EUA-granted-to-Biocerna-SARS-CoV-2-test.html"},{"num":"27","id":12,"title":"Antigen tests: the coronavirus 'breakthrough' that a top White House official says we need","date":{"date":"2020-04-28 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Dr. Deborah Birx, the White House coronavirus response coordinator, says current technology makes it impossible to test every American for coronavirus. The United States, she says, will need a \"breakthrough\" in testing to screen large numbers of people.

According to Birx, that breakthrough is antigen testing. Often used to check for the flu and strep, antigen tests look for pieces of a virus -- often the proteins that cover its surface.","link":"https:\/\/www.cnn.com\/2020\/04\/27\/health\/antigen-tests-coronavirus-breakthrough\/index.html"},{"num":"28","id":11,"title":"U.S. Grant Speeds This PA. Coronavirus Test to Market This Year","date":{"date":"2020-04-18 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"It would help get Americans back to work if we could each sit at home, run a special swab around our teeth, dip it in fluid, and have a marker pop up on the handle 20 minutes later to show whether we have a coronavirus infection. Or that we don't.

The U.S. government is paying Bethlehem-based OraSure Technologies to speed such a test for federal emergency approval as soon as August. If it's cleared and proves accurate, chief executive Stephen Tang says, his company hopes to be making millions of home test kits by December.","link":"https:\/\/www.inquirer.com\/business\/phillydeals\/coronavirus-tang-orasure-saliva-testing-fda-20200418.html"},{"num":"29","id":10,"title":"OraSure Technologies Leverages Expertise in At-Home, Saliva-Based Dx For Coronavirus Antigen Assay","date":{"date":"2020-04-10 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Most testing for SARS-CoV-2 has so far relied on patients having to go to a provider in order to find out whether they may be infected with the coronavirus. And while interest is high in at-home diagnostic tests that make it easier for consumers to determine their coronavirus status, questions abound about their sensitivity, dependability, and overall clinical utility.","link":"https:\/\/www.360dx.com\/immunoassays\/orasure-technologies-leverages-expertise-home-saliva-based-dx-coronavirus-antigen-assay#.XpB2b6BKjD4"},{"num":"30","id":9,"title":"U.S. government funds OraSure's at-home spit test for coronavirus infections","date":{"date":"2020-04-07 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"The U.S. federal government's Biomedical Advanced Research and Development Authority, known as BARDA, has funded the development of a rapid coronavirus test that can be self-administered at home.

Designed by OraSure Technologies, the test would not only detect the novel infection that causes COVID-19 but all coronaviruses that can lead to severe respiratory disease, such as the strain behind the previous SARS outbreak of the early 2000s.","link":"https:\/\/www.fiercebiotech.com\/medtech\/us-government-funds-orasure-s-at-home-spit-test-for-coronavirus-infections"},{"num":"31","id":8,"title":"OraSure Technologies Gets $710K BARDA Contract for Coronavirus Self-Test","date":{"date":"2020-04-06 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure Technologies said Monday it has been awarded a $710,310 contract from Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop a pan-SARS-coronavirus antigen test that uses oral fluid samples.

The firm said that the contract will support OraSure's filing for Emergency Use Authorization from the US Food and Drug Administration that would enable use of a...","link":"https:\/\/www.360dx.com\/business-news\/orasure-technologies-gets-710k-barda-contract-coronavirus-self-test?utm_source=Sailthru&utm_medium=email&utm_campaign=360DN%20Mon%202020-04-06&utm_term=360Dx%20Daily%20News#.Xoys0YhKjIU"},{"num":"32","id":7,"title":"Bethlehem's OraSure wins contract to develop in-home coronavirus test. Feds say it would be a 'game-changer'","date":{"date":"2020-04-06 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"The Bethlehem company behind products that rapidly check for HIV, Hepatitis C and Ebola now has another task in front of it: an in-home test that would allow people to find out if they have COVID-19 in as little as 20 minutes.

OraSure Technologies Inc. on Monday announced it has won a $710,310 federal contract to develop a rapid test that would use oral fluid samples. The company said the test would be built on its OraQuick platform and trained personnel would not be needed to administer the test or read the results from the handheld device that looks like a baby spoon.","link":"https:\/\/www.mcall.com\/coronavirus\/mc-biz-orasure-wins-contract-to-develop-coronavirus-in-home-test-20200406-2hrd3ddrr5dj7m655g674vw7me-story.html"},{"num":"33","id":6,"title":"Lehigh Valley Company Working on At-Home COVID-19 Testing Kits","date":{"date":"2020-04-06 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"What if there was a way to test yourself for the novel coronavirus at home? A Lehigh Valley company is working on making that a reality. NBC10's Steven Fisher has the details.","link":"https:\/\/www.nbcphiladelphia.com\/news\/coronavirus\/lehigh-valley-company-working-on-at-home-covid-19-testing-kits\/2354959\/"},{"num":"34","id":5,"title":"OraSure Announces 2019 Full Year and Q4 Financial Results","date":{"date":"2020-02-15 00:00:00.000000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OraSure Technologies reported after the close of the market on Wednesday that its fourth quarter revenues dipped 1 percent year over year.

For the three months ended Dec. 31, 2019, the point-of-care diagnostic testing and specimen collection device manufacturer reported revenues of $49.7 million, down from $50.2 million a year ago.","link":"https:\/\/www.360dx.com\/business-news\/orasure-technologies-q4-revenues-down-1-percent?utm_source=Sailthru&utm_medium=email&utm_campaign=360DN%20Thurs%202020-02-20&utm_term=360Dx%20Daily%20News#.Xk6cwGhKhhG"},{"num":"35","id":2,"title":"DNA Genotek Announces FDA General Use Clearance for Oragene Dx Family of Products","date":{"date":"2020-01-22 08:00:14.770000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"OTTAWA, Jan. 22, 2020 (GLOBE NEWSWIRE) -- DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that the U.S. Food and Drug Administration (FDA) has granted a general use 510(k) clearance for its Oragene® Dx family of products....","link":"https:\/\/www.globenewswire.com\/news-release\/2020\/01\/22\/1973499\/0\/en\/DNA-Genotek-Announces-FDA-General-Use-Clearance-for-Oragene-Dx-Family-of-Products.html"},{"num":"36","id":3,"title":"JP Morgan Healthcare Day 3: Natera, Exact Sciences, Accelerate Dx, GenMark, OraSure, Quidel, Invitae, Opko","date":{"date":"2020-01-15 08:06:47.040000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"With one day left, the 38th annual JP Morgan Healthcare Conference continued on Wednesday with diagnostics companies presenting before thousands of investors. Below are brief reports on the presentations and breakout sessions covered by our team at the conference. For our previous...","link":"https:\/\/www.360dx.com\/sequencing\/jp-morgan-healthcare-day-3-natera-exact-sciences-accelerate-dx-genmark-orasure-quidel?utm_source=Sailthru&utm_medium=email&utm_campaign=360DN%20Thurs%202020-01-16&utm_term=360Dx%20Daily%20News#.Xir5KmhKhhG"},{"num":"37","id":4,"title":"What the Rebirth of This Old Steel Center Means for Trump","date":{"date":"2020-01-09 08:08:19.267000","timezone_type":3,"timezone":"Europe\/Dublin"},"teaser":"Just a few blocks from the rusted 16-story blast furnaces that once fired hulking steel beams for the Hoover Dam and the Golden Gate Bridge, OraSure Technologies each day produces thousands of thumbnail-size pads made to spit on.These oral swabs, part of a home H.I.V. test kit, are products of a matrix of manufacturers, financial companies and health care institutions powering the Lehigh Valley's $41 billion economy.","link":"https:\/\/www.nytimes.com\/2020\/01\/09\/business\/economy\/trump-pennsylvania-economy.html"}]}